ContextVision AB (OL:CONTX) — Market Cap & Net Worth
Market Cap & Net Worth: ContextVision AB (CONTX)
ContextVision AB (OL:CONTX) has a market capitalization of $26.97 Million (Nkr256.31 Million) as of August 1, 2026. Listed on the OL stock exchange, this Norway-based company holds position #24045 globally and #223 in its home market, demonstrating a 5.20% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ContextVision AB's stock price Nkr3.44 by its total outstanding shares 74509623 (74.51 Million). See ContextVision AB capex to cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
ContextVision AB Market Cap History: 2015 to 2026
ContextVision AB's market capitalization history from 2015 to 2026. Data shows growth from $19.90 Million to $26.97 Million (4.61% CAGR).
ContextVision AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ContextVision AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.30x
ContextVision AB's market cap is 0.30 times its annual revenue
Latest Price to Earnings (P/E) Ratio
42.24x
ContextVision AB's market cap is 42.24 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $37.31 Million | $81.92 Million | $4.25 Million | 0.46x | 8.77x |
| 2017 | $43.34 Million | $80.51 Million | -$1.71 Million | 0.54x | N/A |
| 2018 | $41.61 Million | $90.90 Million | -$1.18 Million | 0.46x | N/A |
| 2019 | $78.40 Million | $95.31 Million | $7.40 Million | 0.82x | 10.60x |
| 2020 | $166.59 Million | $94.75 Million | $12.08 Million | 1.76x | 13.79x |
| 2021 | $124.38 Million | $98.10 Million | -$7.65 Million | 1.27x | N/A |
| 2022 | $68.90 Million | $117.83 Million | $28.79 Million | 0.58x | 2.39x |
| 2023 | $60.37 Million | $132.19 Million | $32.73 Million | 0.46x | 1.84x |
| 2024 | $43.12 Million | $130.67 Million | $24.68 Million | 0.33x | 1.75x |
| 2025 | $33.24 Million | $110.28 Million | $787.00K | 0.30x | 42.24x |
Competitor Companies of CONTX by Market Capitalization
Companies near ContextVision AB in the global market cap rankings as of August 1, 2026.
Key companies related to ContextVision AB by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #980 globally with a market cap of $27.24 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1931 globally with a market cap of $11.99 Billion USD ( AU$16.95 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2123 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2675 globally with a market cap of $7.62 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #980 | Veeva Systems Inc Class A | NYSE:VEEV | $27.24 Billion | $203.78 |
| #1931 | Pro Medicus Ltd | AU:PME | $11.99 Billion | AU$162.21 |
| #2123 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $59.71 |
| #2675 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $7.62 Billion | $43.87 |
ContextVision AB Historical Marketcap From 2015 to 2026
Between 2015 and today, ContextVision AB's market cap moved from $19.90 Million to $ 26.97 Million, with a yearly change of 4.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr26.97 Million | -18.87% |
| 2025 | Nkr33.24 Million | -22.91% |
| 2024 | Nkr43.12 Million | -28.57% |
| 2023 | Nkr60.37 Million | -12.38% |
| 2022 | Nkr68.90 Million | -44.61% |
| 2021 | Nkr124.38 Million | -25.34% |
| 2020 | Nkr166.59 Million | +112.50% |
| 2019 | Nkr78.40 Million | +88.41% |
| 2018 | Nkr41.61 Million | -4.00% |
| 2017 | Nkr43.34 Million | +16.16% |
| 2016 | Nkr37.31 Million | +87.50% |
| 2015 | Nkr19.90 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of ContextVision AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.97 Million USD |
| MoneyControl | $26.97 Million USD |
| MarketWatch | $26.97 Million USD |
| marketcap.company | $26.97 Million USD |
| Reuters | $26.97 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ContextVision AB
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image … Read more